Clinical Trial Update: A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, absorption, breakdown and elimination of R306465 in patients with advanced solid tumors; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• R306465

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED